celecoxib has been researched along with Insulin Sensitivity in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the effects of metformin and celecoxib on obesity-induced adipose tissue inflammation, insulin resistance (IR), fatty liver, and high blood pressure in high-fat (HF) fed rats." | 7.83 | Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver. ( Hsieh, PS; Hung, YJ; Lu, CH, 2016) |
| "We investigated the effects of metformin and celecoxib on obesity-induced adipose tissue inflammation, insulin resistance (IR), fatty liver, and high blood pressure in high-fat (HF) fed rats." | 3.83 | Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver. ( Hsieh, PS; Hung, YJ; Lu, CH, 2016) |
| " The whole body insulin resistance of HFa indicated by the increased fasting plasma insulin levels and the elevated area under curve of insulin obtained from the oral glucose tolerance test were significantly reversed in those combined with celecoxib and nimesulid administration compared with those in HFr." | 3.77 | The importance of cyclooxygenase 2-mediated oxidative stress in obesity-induced muscular insulin resistance in high-fat-fed rats. ( Chen, CH; Hsia, TL; Hsieh, CH; Hsieh, PS; Huang, DW; Tian, YF, 2011) |
| "This study demonstrates that a therapeutic dose of celecoxib, but not piroxicam, could significantly attenuate fructose-induced whole body and muscular insulin resistance in rats." | 3.74 | Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats. ( Chan, JY; Cheng, WT; Hsieh, PS; Kuo, CH; Liu, TT; Shyu, JF; Tsai, HC, 2008) |
| "Body weight was increased significantly and similarly in HFa, HFa-Cel, and HFa-Mes." | 1.35 | COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. ( Chan, PC; Chen, CH; Chiang, CF; Hsieh, PS; Jin, JS; Shih, KC, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, CH | 1 |
| Hung, YJ | 1 |
| Hsieh, PS | 4 |
| Tsai, HC | 1 |
| Kuo, CH | 1 |
| Chan, JY | 1 |
| Shyu, JF | 1 |
| Cheng, WT | 1 |
| Liu, TT | 1 |
| Jin, JS | 1 |
| Chiang, CF | 1 |
| Chan, PC | 1 |
| Chen, CH | 2 |
| Shih, KC | 1 |
| Tian, YF | 1 |
| Hsia, TL | 1 |
| Hsieh, CH | 1 |
| Huang, DW | 1 |
| González-Ortiz, M | 1 |
| Martínez-Abundis, E | 1 |
| Balcázar-Muñoz, BR | 1 |
| Robles-Cervantes, JA | 1 |
1 trial available for celecoxib and Insulin Sensitivity
| Article | Year |
|---|---|
Inhibition of cyclooxygenase-1 or -2 on insulin sensitivity in healthy subjects.
Topics: Adult; Aspirin; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxy | 2001 |
4 other studies available for celecoxib and Insulin Sensitivity
| Article | Year |
|---|---|
Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver.
Topics: Adipocytes; Adipokines; Adipose Tissue; AMP-Activated Protein Kinases; Animals; Blood Pressure; Body | 2016 |
Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats.
Topics: Animals; Blood Glucose; Blood Pressure; Celecoxib; Cyclooxygenase Inhibitors; Fructose; Immunoblotti | 2008 |
COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Blood Glucose; Body Weight; Celecoxib; Cell Size; | 2009 |
The importance of cyclooxygenase 2-mediated oxidative stress in obesity-induced muscular insulin resistance in high-fat-fed rats.
Topics: Adipose Tissue; Animals; Biomarkers; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diet, R | 2011 |